ANAPTYSBIO, INC·4

Dec 10, 5:38 PM ET

Londei Marco 4

4 · ANAPTYSBIO, INC · Filed Dec 10, 2019

Insider Transaction Report

Form 4
Period: 2019-12-06
Londei Marco
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-12-06+98,00098,000 total
    Exercise: $14.02Exp: 2029-12-05Common Stock (98,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION